<span item_type="fundamental" item_id="99b563d3416c6d1f54404750e5785329" counter_id="ST/US/SVVC" env="prod"></span><span item_type="announcement" item_id="549435215589542785" env="prod"></span><p>EPS: As of FY2025 Q2, the actual value is USD -0.01.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Exchange-Traded/Money Market Funds</strong>: 67.6% of the portfolio as of June 30, 2025, compared to 70.3% as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li><li><strong>Advanced Materials</strong>: 25.1% of the portfolio as of June 30, 2025, compared to 0.0% as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li><li><strong>Equipment Leasing</strong>: 3.5% of the portfolio as of June 30, 2025, compared to 2.8% as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li><li><strong>Medical Devices</strong>: 0.6% of the portfolio as of June 30, 2025, compared to 2.4% as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Investment Income/(Loss)</strong>: - $63,174 for the three months ended June 30, 2025, compared to - $178,811 for the three months ended June 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li><li><strong>Net Realized and Unrealized Losses on Investments</strong>: - $26,788 for the three months ended June 30, 2025, compared to $1,028,811 for the three months ended June 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Provided by Operating Activities</strong>: $135 for the three months ended June 30, 2025, compared to $63 for the three months ended June 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Net Unrealized Depreciation on Portfolio Investments</strong>: - $91,590,233 as of June 30, 2025, compared to - $128,112,931 as of June 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company aims to invest at least 80% of its net assets in technology companies, focusing on long-term growth of capital through equity and equity-related investments.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li><li><strong>Non-Core Business</strong>: The company may invest up to 30% of the portfolio in opportunistic investments, including securities of public companies that are actively traded or in actively traded derivative securities.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1495584/000143774925026904/sccv20250630_10q.htm"></span></li></ul>

Firsthand Tech Value Fd | 10-Q: FY2025 Q2 EPS: USD -0.01